Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-005756-32Phase 3Completed
Phase 3 trial of isoprenaline in nephrolithiasis, sponsored by Fredericia Hospital. Primary endpoint: Renal pelvic pressure reduction during ureteropyeloscopy. Started Oct 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-005756-32.